CHETAN DEV et al. LONG-TERM CARDIOVASCULAR OUTCOMES AND SAFETY PROFILE OF PCSK9 INHIBITORS IN HIGH-RISK POPULATIONS FOR SECONDARY PREVENTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: A COMPREHENSIVE META-ANALYSIS OF MORTALITY, MAJOR ADVERSE CARDIAC EVENTS, AND METABOLIC IMPACT. Insights – Journal of Health and Rehabilitation, [S. l.], v. 2, n. 2 (Health & Allied), p. 381–388, 2024. DOI: 10.71000/ijhr199. Disponível em: https://insightsjhr.com/index.php/home/article/view/199.. Acesso em: 2 jun. 2026.